The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Healthcare Nanotechnology (Nanomedicine)-Global Market Insights and Sales Trends 2024

Healthcare Nanotechnology (Nanomedicine)-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1863494

No of Pages : 122

Ask Your Query

Synopsis

It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.

The global Healthcare Nanotechnology (Nanomedicine) market size is expected to reach US$ 256040 million by 2029, growing at a CAGR of 3.1% from 2023 to 2029. The market is mainly driven by the significant applications of Healthcare Nanotechnology (Nanomedicine) in various end use industries. The expanding demands from the Anticancer, CNS Product, Anti-infective and Other, are propelling Healthcare Nanotechnology (Nanomedicine) market. Nanomedicine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nano Medical Devices segment is estimated at % CAGR for the next seven-year period.

The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Healthcare Nanotechnology (Nanomedicine), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Healthcare Nanotechnology (Nanomedicine) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Healthcare Nanotechnology (Nanomedicine) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Healthcare Nanotechnology (Nanomedicine) sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Healthcare Nanotechnology (Nanomedicine) covered in this report include Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co and Biogen, etc.

The global Healthcare Nanotechnology (Nanomedicine) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Amgen
  • Teva Pharmaceuticals
  • Abbott
  • UCB
  • Roche
  • Celgene
  • Sanofi
  • Merck & Co
  • Biogen
  • Stryker
  • Gilead Sciences
  • Pfizer
  • 3M Company
  • Johnson & Johnson
  • SmitH& Nephew
  • Leadiant Biosciences
  • Kyowa Hakko Kirin
  • Takeda
  • Ipsen
  • Endo International

Global Healthcare Nanotechnology (Nanomedicine) market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Healthcare Nanotechnology (Nanomedicine) market, Segment by Type:

  • Nanomedicine
  • Nano Medical Devices
  • Nano Diagnosis
  • Other

Global Healthcare Nanotechnology (Nanomedicine) market, by Application

  • Anticancer
  • CNS Product
  • Anti-infective
  • Other

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Healthcare Nanotechnology (Nanomedicine) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Healthcare Nanotechnology (Nanomedicine)
1.1 Healthcare Nanotechnology (Nanomedicine) Market Overview
1.1.1 Healthcare Nanotechnology (Nanomedicine) Product Scope
1.1.2 Healthcare Nanotechnology (Nanomedicine) Market Status and Outlook
1.2 Global Healthcare Nanotechnology (Nanomedicine) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Healthcare Nanotechnology (Nanomedicine) Market Size by Region (2018-2029)
1.4 Global Healthcare Nanotechnology (Nanomedicine) Historic Market Size by Region (2018-2023)
1.5 Global Healthcare Nanotechnology (Nanomedicine) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Healthcare Nanotechnology (Nanomedicine) Market Size (2018-2029)
1.6.1 North America Healthcare Nanotechnology (Nanomedicine) Market Size (2018-2029)
1.6.2 Europe Healthcare Nanotechnology (Nanomedicine) Market Size (2018-2029)
1.6.3 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size (2018-2029)
1.6.4 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size (2018-2029)
1.6.5 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size (2018-2029)
2 Healthcare Nanotechnology (Nanomedicine) Market by Type
2.1 Introduction
2.1.1 Nanomedicine
2.1.2 Nano Medical Devices
2.1.3 Nano Diagnosis
2.1.4 Other
2.2 Global Healthcare Nanotechnology (Nanomedicine) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Healthcare Nanotechnology (Nanomedicine) Historic Market Size by Type (2018-2023)
2.2.2 Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Healthcare Nanotechnology (Nanomedicine) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Healthcare Nanotechnology (Nanomedicine) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Healthcare Nanotechnology (Nanomedicine) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Healthcare Nanotechnology (Nanomedicine) Revenue Breakdown by Type (2018-2029)
3 Healthcare Nanotechnology (Nanomedicine) Market Overview by Application
3.1 Introduction
3.1.1 Anticancer
3.1.2 CNS Product
3.1.3 Anti-infective
3.1.4 Other
3.2 Global Healthcare Nanotechnology (Nanomedicine) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Healthcare Nanotechnology (Nanomedicine) Historic Market Size by Application (2018-2023)
3.2.2 Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Healthcare Nanotechnology (Nanomedicine) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Healthcare Nanotechnology (Nanomedicine) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Healthcare Nanotechnology (Nanomedicine) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Healthcare Nanotechnology (Nanomedicine) Revenue Breakdown by Application (2018-2029)
4 Healthcare Nanotechnology (Nanomedicine) Competition Analysis by Players
4.1 Global Healthcare Nanotechnology (Nanomedicine) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Healthcare Nanotechnology (Nanomedicine) as of 2022)
4.3 Date of Key Players Enter into Healthcare Nanotechnology (Nanomedicine) Market
4.4 Global Top Players Healthcare Nanotechnology (Nanomedicine) Headquarters and Area Served
4.5 Key Players Healthcare Nanotechnology (Nanomedicine) Product Solution and Service
4.6 Competitive Status
4.6.1 Healthcare Nanotechnology (Nanomedicine) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Amgen
5.1.1 Amgen Profile
5.1.2 Amgen Main Business
5.1.3 Amgen Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.1.4 Amgen Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.1.5 Amgen Recent Developments
5.2 Teva Pharmaceuticals
5.2.1 Teva Pharmaceuticals Profile
5.2.2 Teva Pharmaceuticals Main Business
5.2.3 Teva Pharmaceuticals Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.2.4 Teva Pharmaceuticals Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.2.5 Teva Pharmaceuticals Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.3.4 Abbott Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.3.5 UCB Recent Developments
5.4 UCB
5.4.1 UCB Profile
5.4.2 UCB Main Business
5.4.3 UCB Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.4.4 UCB Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.4.5 UCB Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.5.4 Roche Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 Celgene
5.6.1 Celgene Profile
5.6.2 Celgene Main Business
5.6.3 Celgene Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.6.4 Celgene Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.6.5 Celgene Recent Developments
5.7 Sanofi
5.7.1 Sanofi Profile
5.7.2 Sanofi Main Business
5.7.3 Sanofi Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.7.4 Sanofi Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.7.5 Sanofi Recent Developments
5.8 Merck & Co
5.8.1 Merck & Co Profile
5.8.2 Merck & Co Main Business
5.8.3 Merck & Co Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.8.4 Merck & Co Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.8.5 Merck & Co Recent Developments
5.9 Biogen
5.9.1 Biogen Profile
5.9.2 Biogen Main Business
5.9.3 Biogen Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.9.4 Biogen Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.9.5 Biogen Recent Developments
5.10 Stryker
5.10.1 Stryker Profile
5.10.2 Stryker Main Business
5.10.3 Stryker Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.10.4 Stryker Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.10.5 Stryker Recent Developments
5.11 Gilead Sciences
5.11.1 Gilead Sciences Profile
5.11.2 Gilead Sciences Main Business
5.11.3 Gilead Sciences Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.11.4 Gilead Sciences Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.11.5 Gilead Sciences Recent Developments
5.12 Pfizer
5.12.1 Pfizer Profile
5.12.2 Pfizer Main Business
5.12.3 Pfizer Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.12.4 Pfizer Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.12.5 Pfizer Recent Developments
5.13 3M Company
5.13.1 3M Company Profile
5.13.2 3M Company Main Business
5.13.3 3M Company Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.13.4 3M Company Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.13.5 3M Company Recent Developments
5.14 Johnson & Johnson
5.14.1 Johnson & Johnson Profile
5.14.2 Johnson & Johnson Main Business
5.14.3 Johnson & Johnson Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.14.4 Johnson & Johnson Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.14.5 Johnson & Johnson Recent Developments
5.15 SmitH& Nephew
5.15.1 SmitH& Nephew Profile
5.15.2 SmitH& Nephew Main Business
5.15.3 SmitH& Nephew Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.15.4 SmitH& Nephew Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.15.5 SmitH& Nephew Recent Developments
5.16 Leadiant Biosciences
5.16.1 Leadiant Biosciences Profile
5.16.2 Leadiant Biosciences Main Business
5.16.3 Leadiant Biosciences Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.16.4 Leadiant Biosciences Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.16.5 Leadiant Biosciences Recent Developments
5.17 Kyowa Hakko Kirin
5.17.1 Kyowa Hakko Kirin Profile
5.17.2 Kyowa Hakko Kirin Main Business
5.17.3 Kyowa Hakko Kirin Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.17.4 Kyowa Hakko Kirin Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.17.5 Kyowa Hakko Kirin Recent Developments
5.18 Takeda
5.18.1 Takeda Profile
5.18.2 Takeda Main Business
5.18.3 Takeda Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.18.4 Takeda Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.18.5 Takeda Recent Developments
5.19 Ipsen
5.19.1 Ipsen Profile
5.19.2 Ipsen Main Business
5.19.3 Ipsen Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.19.4 Ipsen Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.19.5 Ipsen Recent Developments
5.20 Endo International
5.20.1 Endo International Profile
5.20.2 Endo International Main Business
5.20.3 Endo International Healthcare Nanotechnology (Nanomedicine) Products, Services and Solutions
5.20.4 Endo International Healthcare Nanotechnology (Nanomedicine) Revenue (US$ Million) & (2018-2023)
5.20.5 Endo International Recent Developments
6 North America
6.1 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Healthcare Nanotechnology (Nanomedicine) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Healthcare Nanotechnology (Nanomedicine) Market Dynamics
11.1 Healthcare Nanotechnology (Nanomedicine) Industry Trends
11.2 Healthcare Nanotechnology (Nanomedicine) Market Drivers
11.3 Healthcare Nanotechnology (Nanomedicine) Market Challenges
11.4 Healthcare Nanotechnology (Nanomedicine) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock